Arch Therapeutics, Inc. (ARTH)

Number of records: 23
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
08-Sep-23 5:47 PM
View: 
Hicks Laurence
Director
Arch Therapeutics, Inc. (ARTH) 31-Aug-23Private Purchase
Duplicate
10,292$0.28$2,830.30100%
0 to 10.29K
08-Sep-23 5:47 PM
View: 
Norchi Terrence W
PRESIDENT AND CHIEF EXECUTIVE
Director
Arch Therapeutics, Inc. (ARTH) 31-Aug-23Private Purchase 6,862$0.28$1,887.05100%
0 to 6.86K
08-Sep-23 5:47 PM
View: 
Abrams Michael S
Chief Financial Officer
Arch Therapeutics, Inc. (ARTH) 31-Aug-23Private Purchase 10,292$0.28$2,830.30100%
0 to 10.29K
08-Jul-22 4:53 PM
View: 
Hicks Laurence
Director
Arch Therapeutics, Inc. (ARTH) 06-Jul-22Grant
Duplicate
108,652----100%
0 to 108.65K
08-Jul-22 4:55 PM
View: 
Norchi Terrence W
PRESIDENT AND CHIEF EXECUTIVE
Arch Therapeutics, Inc. (ARTH) 06-Jul-22Grant 72,435----< 1%
12.91M to 12.98M
08-Jul-22 4:57 PM
View: 
Abrams Michael S
Chief Financial Officer
Arch Therapeutics, Inc. (ARTH) 06-Jul-22Grant 108,652----100%
0 to 108.65K
23-Jun-20 7:59 AM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 22-Jun-20Exercise (out-of-the-money) 454,546$81,818.30$37,190,201,344.0035%
1.29M to 1.75M
20-Jul-18 12:04 PM
View: 
Norchi Terrence W
President & CEO
Director
10% Owner
Arch Therapeutics, Inc. (ARTH) 19-Jul-18Grant 360,000----11%
3.2M to 3.56M
20-Jul-18 12:00 PM
View: 
Dhillon Avtar S
Director
Arch Therapeutics, Inc. (ARTH) 19-Jul-18Grant 220,000----3%
8.3M to 8.52M
20-Jul-18 12:05 PM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 19-Jul-18Grant 110,000----42%
260.0K to 370.0K
20-Jul-18 12:04 PM
View: 
Davis Richard E
CFO & TREASURER
Arch Therapeutics, Inc. (ARTH) 19-Jul-18Grant 275,000----46%
603.0K to 878.0K
18-Jul-18 2:33 PM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 16-Jul-18Option Exercise 30,000$0.37$11,100.0013%
230.0K to 260.0K
06-Feb-17 11:28 AM
View: 
Dhillon Avtar S
Director
Arch Therapeutics, Inc. (ARTH) 03-Feb-17Grant 400,000----5%
7.9M to 8.3M
06-Feb-17 11:29 AM
View: 
Norchi Terrence W
President & CEO
Director
10% Owner
Arch Therapeutics, Inc. (ARTH) 03-Feb-17Grant 650,000----25%
2.55M to 3.2M
06-Feb-17 11:26 AM
View: 
Davis Richard E
CFO & TREASURER
Arch Therapeutics, Inc. (ARTH) 03-Feb-17Grant 500,000----485%
103.0K to 603.0K
06-Feb-17 11:30 AM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 03-Feb-17Grant 200,000----667%
30.0K to 230.0K
31-May-16 1:15 PM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 26-May-16Purchase 111,111----15%
757.82K to 868.93K
05-May-16 12:42 PM
View: 
Sulat James R
Director
Arch Therapeutics, Inc. (ARTH) 03-May-16Grant 30,000----100%
0 to 30.0K
05-May-16 12:43 PM
View: 
Davis Richard E
CFO & TREASURER
Arch Therapeutics, Inc. (ARTH) 03-May-16Grant 103,000----100%
0 to 103.0K
05-May-16 12:41 PM
View: 
Dhillon Avtar S
Director
Arch Therapeutics, Inc. (ARTH) 03-May-16Grant 737,000----10%
7.16M to 7.9M
05-May-16 12:45 PM
View: 
Norchi Terrence W
President & CEO
Director
10% Owner
Arch Therapeutics, Inc. (ARTH) 03-May-16Grant 1,130,000----80%
1.42M to 2.55M
26-Jun-13 5:18 PM
View: 
Norchi Terrence W
Pres, CEO, Sec, and Treas
Director
10% Owner
Arch Therapeutics, Inc. (ARTH) 26-Jun-13Acquisition (other) 1,419,080----14%
10.0M to 11.42M
26-Jun-13 5:16 PM
View: 
Dhillon Avtar S
Director
10% Owner
Arch Therapeutics, Inc. (ARTH) 25-Jun-13Acquisition (other) 160,373----2%
7.0M to 7.16M